+972548034532 info@resultmed.com
Melanoma Immunotherapy in Israel


Immunotherapy for melanoma



Immunotherapy is one of the latest promising methods for melanoma treatment. It works successfully stimulating the body’s immune system in order to increase its ability to identify and kill cancer cells.


Prof. Schachter is a leading expert with many years of experience in immunotherapy for melanoma in Israel.


Prof. Yakov Shekhter

Prof. Jacob Schachter – Head of the Ella Lamelbaum Institute for Melanoma and Immunooncology at Sheba Academic Medical Center, Chaim Sheba Hospital, Israel.
Deputy Director of Oncology Department of Chaim Sheba Hospital.


Immune system protects the body from attacking infections caused by viruses and bacteria and abnormal cells of the human body (cancer) as well. Usually immune system is able to distinguish healthy normal cells from abnormal cells. But sometimes this mechanism does not work it cannot identify melanoma as dangerous cells.


Our oncologists use systemic immunotherapy in Israel for the treatment of metastatic cancer.


Medicines that were approved by FDA for melanoma immunotherapy:

♦ Ipilimumab (Yrvoy) – an antibody CTLA-4.
♦ Pembrolizumab (Keytruda) – an anti-PD-1.
♦ Nivolumab (Opdivo) – an anti-PD-1.
♦ Nivolumab (Opdivo) + Ipilimum (Yervoy) combination.

♦ TIL (tumour-infiltrating lymphocytes) – new kind of immunotherapy used in Israel for the treatment of metastatic melanoma.


Other treatments for melanoma:

⇒ Microsurgical operation (Mohs Surgery)

Targeted therapy

Ajuvant therapy

Radiation therapy


Call-CenterShould you have any question or you need to schedule an appointment, please contact us at +972 54-803-4532, email: info@resultmed.com or fill out the application form


We will contact you as soon as possible.


ResultMed Team  



ResultMed provides medical treatment organization and coordination services for foreign patients only.


       !מבקרים באתר היקרים, אנא שימו לב

.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד


For foreign patients:


Viber, WhatsApp, Telegram + 972 54 803 45 32



Are you a foreign patient? Please send your request

LDH analysis for melanoma treatment prognosis – study

A recent study, which appeared in the Journal of Clinical Oncology, may shed light on whether immunotherapy can really cure melanoma patients.

Read More

TIL therapy for melanoma

TIL therapy of melanoma at leading Israeli oncologist

TIL (tumour-infiltrating lymphocytes) is one of the new modern kind of immunotherapy that used in Israel for the treatment of metastatic melanoma.

Read More